13/17. Aggarwal, S & Aggarwal, S.

2016, ‘Placenta Accreta Prenatal Diagnosis: Does MRI add

to Sonography?’, Journal of Gynaecology and Womwn’s Health, pp, 1-2
4/9. American College of Obstetricians and Gynecologists -Obstetric Care Consensus 2018,
‘Placenta Accreta Spectrum’. American College of Obstetricians and Gynecologists,
Washington D.C, vol. 132, no. 6.
6/11. Balayla J, Bondarenko HD. Placenta accreta and the risk of adverse maternal and neonatal
outcomes. J. Perinat. Med. 2013; 41(2): 141—149. DOI 10.1515/jpm2012-0219
21/25. Bartels, H. C, et al. 2018, ‘Placenta Accreta Spectrum: A Review Pathology, Molecular
Biology and Biomarkers’, Hindawi, London, vol. 2018.
20/24..Baughman W, Corteville JE. Et al. RadioGraphics Journal from The Departement Of
Radology and Obstetrics and Gynecology : Placenta Accreta Spectrum Of US and MR
Imaging Findings. Vol 28. Pp 1905-1917. Ohio : Nov-Dec. 2008.
11/15. Berkley, E. M. & Abuhamad, A. Z. 2013, ‘Prenatal diagnosis of placenta accreta: Is
sonography all we need?, Journal of Ultrasound in Medicine, pp.13451350
19/23. Cali G, Forlani F, Lees C, Timor‐Tritsch I, Palacios‐Jaraquemada J, Dall'Asta A et al.
Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound in
Obstetrics & Gynecology. 2019
14/18. Comstock, C., H. 2011, ‘ The antenatal diagnosis of placental attachment disorder’ ,
Current Opinion in Obstetrics & Gynecology , pp 117-122
23/27. Cunningham F, & Leveno K.J., & Bloom S.L., & Dashe J.S., & Hoffman B.L., & Casey
B.M., & Spong C.Y. (2022). Williams Obstetrics, 26e. McGraw Hill.
25/29. Eller, A. G., Porter, T. F., Soisson, P., & Silver, R. M. 2009, Optimal management
strategies for placenta accreta. BJOG: an international journal of obstetrics and
gynaecology, 116(5), 648–654. https://doi.org/10.1111/j.1471-0528.2008.02037.x
5/10. Farquhar CM, Li Z, Lensen S, et al. Incidence, risk factors and perinatal outcomes for
placenta accreta in Australia and New Zealand: a case–control study. BMJ Open
2017;7:e017713. doi:10.1136/bmjopen-2017-017713
8/13. Fauzan., Iswari, W. A., Pardede, T. U., Darus, F., Puspitasari, B., Santana, S., Abidin, F.,
& Endjun, J. J. 2017 ‘ USG untuk Deteksi Plasenta Akreta’ , vol. 44, no.8 pp 586-590
22/26. Fitri, D. R., & Mutiara, H. 2017, G2P1A0 Berusia 41 Tahun dengan plasenta akreta. J
Medula Unila, 7(2), 37–41.
12/16. Garmi, G., & Salim, R. 2012, ‘Epidemiology, Etiology, Diagnosis, and Management of
Placenta Accreta’ , Obstetrics and Gynecology International, pp 1-7
9/14. Goh, W., & Zalud, I. 2016, ‘ Placenta accreta: Diagnosis, management and the molecular
biology of the morbidly adherent placenta’ , HHS Public Access, pp 1-13
27/32. Grace Tan, S. E., Jobling, T. W., Wallace, E. M., McNeilage, L. J., Manolitsas, T., &
Hodges, R. J. 2013, Surgical management of placenta accreta: a 10-year experience. Acta
obstetricia et gynecologica Scandinavica, 92(4), 445–450.
https://doi.org/10.1111/aogs.12075
3/8. Hecht, J. L., Baergen, R., Ernst, L. M., Katzman, P. J., Jacques, S. M., Jauniaux, E., Khong,
T. Y., Metlay, L. A., Poder, L., Qureshi, F., Rabban, J. T., 3rd, Roberts, D. J., Shainker, S., &
Heller, D. S. (2020). Classification and reporting guidelines for the pathology diagnosis of
placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Modern
pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
33(12), 2382–2396. https://doi.org/10.1038/s41379-020-0569-1
10/6.Jauniaux, E., Ayres-de-Campos, D., Langhoff-Roos, J., Fox, K. A., Collins, S., & FIGO
Placenta Accreta Diagnosis and Management Expert Consensus Panel (2019). FIGO
classification for the clinical diagnosis of placenta accreta spectrum disorders. International
journal of gynaecology and obstetrics: the official organ of the International Federation of
Gynaecology and Obstetrics, 146(1), 20–24. https://doi.org/10.1002/ijgo.12761
2/7. Jauniaux, E., Chantraine, F., Silver, R. M., Langhoff-Roos, J., & FIGO Placenta Accreta
Diagnosis and Management Expert Consensus Panel (2018). FIGO consensus guidelines on
placenta accreta spectrum disorders: Epidemiology. International journal of gynaecology and
obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
140(3), 265–273. https://doi.org/10.1002/ijgo.12407
28/33. Jauniaux, E., Collins, S., & Burton, G. J. (2018). Placenta accreta spectrum:
pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. American
journal of obstetrics and gynecology, 218(1), 75–87.
https://doi.org/10.1016/j.ajog.2017.05.067
Jauniaux E, Zosmer N, Subramanian D, Shaikh H, Burton GJ. Ultrasound-histopathologic
features of the utero-placental inter- face in placenta accreta spectrum. Placenta. 2020;97:58-
64.
31/36. Jauniaux E, Hussein AM, Elbarmelgy RM, Elbarmelgy RA, Burton GJ. Failure of
placental detachment in accreta placentation is associated with excessive fibrinoid deposition
at the utero- placental interface. Am J Obstet Gynecol. 2021;S0002- 9378(21):00960–1.
17/21. Guleria K, Gupta B, Agarwal S. et al. ACTA Obstetricia et Gynecologica Scandinavica.
Vol 92. pp. 461-464. India :2013.
15/19. Leyendecker, JR, Dubose ,Melinda. Et al. AJR. Women’s Imaging : MRI of Pregnancy-
Related Issues : Abnormal Placentation. American: October 2011. pp 311-320
7/12. Lyell, D. J. 2017, ‘Placenta Accreta Diagnosis and Management of Placenta Accreta’.
Morlando M, Collins S. Placenta Accreta Spectrum Disorders: Challenges, Risks, and
Management Strategies. Int J Womens Health. 2020 Nov 10;12:1033-1045. doi:
10.2147/IJWH.S224191. PMID: 33204176; PMCID: PMC7667500.
29/34. Mulla, B. M., Weatherford, R., Redhunt, A. M., Modest, A. M., Hacker, M. R., Hecht, J.
L., Spiel, M. H., & Shainker, S. A. 2019, Hemorrhagic morbidity in placenta accreta
spectrum with and without placenta previa. Archives of gynecology and obstetrics, 300(6),
1601–1606. https://doi.org/10.1007/s00404-019-05338-y
1. Piñas Carrillo A, Chandraharan E. Placenta accreta spectrum: Risk factors, diagnosis and
management with special reference to the Triple P procedure. Womens Health (Lond). 2019
Jan-Dec;15:1745506519878081. doi: 10.1177/1745506519878081. PMID: 31578123;
PMCID: PMC6777059.
24/28. Putri,Savira Dwi. 2019. Analisis Kejadian Plasenta Akreta di RSUP H. Adam Malik
Medan Tahun 2016-2019. Skripsi.Medan : Universitas Sumatera Utara

Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly
adherent placenta treated with and without a standardized multidisciplinary approach. Am J
Obstet Gynecol. 2015;212(2):218.e1-218.e9.

25/30. Shepherd AM, Mahdy H. 2022, Placenta Accreta. [Updated 2022 Feb 26]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-Available from:
https://www.ncbi.nlm.nih.gov/books/NBK563288/
26/31. Silver, R. M., & Barbour, K. D. 2015, Placenta accreta spectrum: accreta, increta, and
percreta. Obstetrics and gynecology clinics of North America, 42(2), 381–402.
https://doi.org/10.1016/j.ogc.2015.01.014
16/20. Sze-yan C. Interational Journal ofWomen’s Health. The Sonographic Appearance and
Obstetric Management of Placenta Accreta. Pp 587- 594. Hong Kong- 2012.

18/22. Rac MWF, Dashez JS, Wells E, Moschos E, Mclntire D D, Twickler DM,2015 Ultrasound
predictors of placental invasion: the Placenta Accreta Index. Pubmed

32/4 Guo Z, Han X, Zhang H, Zheng W, Yang H, Ma J. Association Between Pre-delivery

Coagulation Indicators and Invasive Placenta Accreta Spectrum. Clin Appl Thromb Hemost.
2022 Jan-Dec;28:10760296211070580. doi: 10.1177/10760296211070580. PMID: 34994211;
PMCID: PMC8762652.

33/37. Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F. Standardization of prothrombin

time/international normalized ratio (PT/INR). Int J Lab Hematol. 2021;43(1):21-28.

34/38. Shainker SA, Silver RM, Modest AMet al. Placenta accreta spectrum: biomarker
discovery using plasma proteomics. Am J Obstet Gynecol. 2020;223(3):433.e1–433.e14.

35/39. Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of
thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(4):709-725.

30/35. Shamshirsaz AA, Fox KA, Erfani Het al. Coagulopathy in surgical management of
placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2019;237:126-130.